Approximately 20% of Shigella isolates tested in New York City, New York, USA, during 2013–2015 displayed decreased azithromycin susceptibility. Case-patients were older and more frequently male and HIV infected than those with azithromycin-susceptible Shigella infection; 90% identified as men who have sex with men. Clinical interpretation guidelines for azithromycin resistance and outcome studies are needed
Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typ...
Antimicrobial resistance of Shigella isolates in Bangladesh, during 2001-2002, was studied and com-p...
Shigella species remains a major diarrhoeagenic agent, affecting mostly children, with global high i...
Approximately 20% of Shigella isolates tested in New York City, New York, USA, during 2013-2015 disp...
BackgroundShigella spp. cause ~500,000 illnesses in the United States annually. Antibiotics are reco...
Shigella spp. cause ≈500,000 illnesses in the United States annually, and resistance to ciprofloxaci...
Appropriate antibiotic treatment of shigellosis depends on identifying resistance patterns. By study...
Bacteria of the genus Shigella cause approximately 500,000 illnesses each year in the United States....
Antimicrobial resistance of Shigella isolates in Bangladesh, during 2001-2002, was studied and comp...
During 2012–2013 in Montreal, Canada, 4 locally acquired Shigella spp. pulse types with the mph(A) g...
ABSTRACTShigellosis is a major cause of diarrhoea-related morbidity and mortality, especially in dev...
acquired Shigella spp. pulse types with the mph(A) gene and reduced susceptibility to azithromycin ...
Abstract Azithromycin (AZM) resistance among Shigella is a major public health concern. Here, we inv...
Antimicrobial resistance of Shigella isolates in Bangladesh, during 2001-2002, was studied and compa...
We characterized 20 Shigella isolates with decreased susceptibility to fluoroquinolones. Most patien...
Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typ...
Antimicrobial resistance of Shigella isolates in Bangladesh, during 2001-2002, was studied and com-p...
Shigella species remains a major diarrhoeagenic agent, affecting mostly children, with global high i...
Approximately 20% of Shigella isolates tested in New York City, New York, USA, during 2013-2015 disp...
BackgroundShigella spp. cause ~500,000 illnesses in the United States annually. Antibiotics are reco...
Shigella spp. cause ≈500,000 illnesses in the United States annually, and resistance to ciprofloxaci...
Appropriate antibiotic treatment of shigellosis depends on identifying resistance patterns. By study...
Bacteria of the genus Shigella cause approximately 500,000 illnesses each year in the United States....
Antimicrobial resistance of Shigella isolates in Bangladesh, during 2001-2002, was studied and comp...
During 2012–2013 in Montreal, Canada, 4 locally acquired Shigella spp. pulse types with the mph(A) g...
ABSTRACTShigellosis is a major cause of diarrhoea-related morbidity and mortality, especially in dev...
acquired Shigella spp. pulse types with the mph(A) gene and reduced susceptibility to azithromycin ...
Abstract Azithromycin (AZM) resistance among Shigella is a major public health concern. Here, we inv...
Antimicrobial resistance of Shigella isolates in Bangladesh, during 2001-2002, was studied and compa...
We characterized 20 Shigella isolates with decreased susceptibility to fluoroquinolones. Most patien...
Background Shigellosis is an acute, severe bacterial colitis that, in high-income countries, is typ...
Antimicrobial resistance of Shigella isolates in Bangladesh, during 2001-2002, was studied and com-p...
Shigella species remains a major diarrhoeagenic agent, affecting mostly children, with global high i...